BioAtla, Inc.

Historical 13F Holders

Symbol
BCAB
CUSIP
09077B104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 09077B104 since 12/18/2024, newest first.

Filer % of Class Filed
OPOKA INVESTMENT FUND Co 13G 4.8% 10/15/2025
Event 7/9/2025
Acorn Bioventures, L.P. 13G/A Amendment 4
8.3% 5/20/2025
Event 5/15/2025
Highbridge Capital Management, LLC 13G/A Amendment 1 7.7% 4/25/2025
Event 3/31/2025
OPOKA INVESTMENT FUND Co 13G 6.1% 3/18/2025
Event 3/6/2025
Highbridge Capital Management, LLC 13G 9.9% 2/10/2025
Event 12/31/2024
Short Jay M PHD 13G/A Amendment 4
6.6% 2/7/2025
Event 12/31/2024
Millennium Management LLC 13G/A Amendment 1
1.9% 1/24/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 1 108 k $448 k
2026 Q1 36 15.4 M $2.47 M
2025 Q4 42 13.2 M $7.49 M
2025 Q3 46 13.4 M $9.19 M
2025 Q2 41 13.2 M $5.21 M
2025 Q1 46 13.7 M $4.77 M
2024 Q4 73 28.0 M $16.6 M
2024 Q3 69 17.7 M $31.0 M
2024 Q2 87 24.0 M $33.0 M
2024 Q1 93 29.2 M $100 M
2023 Q4 85 29.0 M $71.4 M
2023 Q3 87 30.1 M $51.3 M
2023 Q2 91 32.0 M $96.1 M
2023 Q1 87 32.9 M $87.9 M
2022 Q4 98 34.0 M $280 M
2022 Q3 82 27.0 M $208 M
2022 Q2 83 23.5 M $67.1 M
2022 Q1 101 25.5 M $128 M
2021 Q4 89 27.1 M $532 M
2021 Q3 88 25.4 M $746 M
2021 Q2 78 21.9 M $926 M
2021 Q1 63 19.0 M $965 M
2020 Q4 54 15.7 M $530 M